Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer. Elez E, Yoshino T, Shen L, Lonardi S, et al. N Engl J Med 2025 May 30. doi: 10.1056/NEJMoa2501912.

Read + Share

Amedeo Smart

Independent Medical Education

Elez E, Yoshino T, Shen L, Lonardi S, et al. Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer. N Engl J Med 2025 May 30. doi: 10.1056/NEJMoa2501912.
PMID: 40444708